TNSN92015A1 - Composition pharmaceutique - Google Patents

Composition pharmaceutique

Info

Publication number
TNSN92015A1
TNSN92015A1 TNTNSN92015A TNSN92015A TNSN92015A1 TN SN92015 A1 TNSN92015 A1 TN SN92015A1 TN TNSN92015 A TNTNSN92015 A TN TNSN92015A TN SN92015 A TNSN92015 A TN SN92015A TN SN92015 A1 TNSN92015 A1 TN SN92015A1
Authority
TN
Tunisia
Prior art keywords
quinone
hydrogen
formula
composition
pharmaceutical composition
Prior art date
Application number
TNTNSN92015A
Other languages
English (en)
French (fr)
Inventor
Washington Odur Ayuko Dr
Original Assignee
Washington Odur Ayuko Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Washington Odur Ayuko Dr filed Critical Washington Odur Ayuko Dr
Publication of TNSN92015A1 publication Critical patent/TNSN92015A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B1/00—Dyes with anthracene nucleus not condensed with any other ring
    • C09B1/02—Hydroxy-anthraquinones; Ethers or esters thereof
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
    • C09B67/0033—Blends of pigments; Mixtured crystals; Solid solutions
    • C09B67/0034—Mixtures of two or more pigments or dyes of the same type
    • C09B67/0038—Mixtures of anthraquinones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TNTNSN92015A 1991-02-13 1992-02-13 Composition pharmaceutique TNSN92015A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919103075A GB9103075D0 (en) 1991-02-13 1991-02-13 Trinitrobenzene derivatives and their therapeutic use

Publications (1)

Publication Number Publication Date
TNSN92015A1 true TNSN92015A1 (fr) 1993-06-08

Family

ID=10689992

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN92015A TNSN92015A1 (fr) 1991-02-13 1992-02-13 Composition pharmaceutique

Country Status (30)

Country Link
EP (1) EP0499467A3 (OSRAM)
JP (1) JPH06505231A (OSRAM)
CN (1) CN1064407A (OSRAM)
AP (1) AP549A (OSRAM)
AU (2) AU1233992A (OSRAM)
BG (1) BG61025B1 (OSRAM)
BR (1) BR9205642A (OSRAM)
CA (1) CA2104009A1 (OSRAM)
CZ (1) CZ166893A3 (OSRAM)
DZ (1) DZ1559A1 (OSRAM)
FI (1) FI933595A0 (OSRAM)
GB (2) GB9103075D0 (OSRAM)
GT (1) GT199200009A (OSRAM)
HU (1) HUT65634A (OSRAM)
IE (1) IE920464A1 (OSRAM)
IL (1) IL100906A (OSRAM)
IN (1) IN178929B (OSRAM)
IS (1) IS3814A (OSRAM)
JO (1) JO1719B1 (OSRAM)
LT (1) LT3197B (OSRAM)
MA (1) MA22443A1 (OSRAM)
MX (1) MX9200622A (OSRAM)
MY (1) MY131098A (OSRAM)
NO (1) NO932681L (OSRAM)
NZ (2) NZ240487A (OSRAM)
OA (2) OA09535A (OSRAM)
SK (1) SK87993A3 (OSRAM)
TN (1) TNSN92015A1 (OSRAM)
WO (1) WO1992014454A1 (OSRAM)
ZA (1) ZA921037B (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103075D0 (en) 1991-02-13 1991-03-27 Washington Odur Ayuko Trinitrobenzene derivatives and their therapeutic use
DZ1781A1 (fr) * 1993-05-21 2002-02-17 Radopah Ltd Agents d'arylation.
AP575A (en) * 1994-03-17 1997-01-31 Radopath Ltd Anti viral and anti cancer agents.
DE59409088D1 (de) * 1994-10-04 2000-02-24 Lohmann Rudolf Lomapharm Lösungen von Anthrachinonen zur parenteralen Applikation
US7482029B2 (en) 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
US7537774B2 (en) * 2005-12-23 2009-05-26 Orion Therapeautics, Llc Therapeutic formulation
JP2010535815A (ja) 2007-08-08 2010-11-25 バイオノボ・インコーポレーテッド モクセイ科トウネズミモチのエストロゲン性抽出物およびその使用
EP2194999A4 (en) 2007-09-07 2012-03-21 Bionovo Inc ESTROGENIC EXTRACTS OF ASTRAGALUS MEMBRANACEUS FISCH.BGE.VAR.MONGOLICUS BGE. THE FAMILY LEGUMINOSAE AND ITS APPLICATIONS
JP2010538093A (ja) 2007-09-07 2010-12-09 バイオノボ・インコーポレーテッド シソ科ファミリーのセイタカナミキソウのエストロゲン性抽出物およびその使用
WO2009033025A1 (en) 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of asparagus conchinchinensis (lour.) merr of the liliaceae family and uses thereof
EP2060562A1 (en) * 2007-11-16 2009-05-20 Laboratoire Medidom S.A. Dioxoanthracene sulphonate derivatives
AU2008326426A1 (en) 2007-11-19 2009-05-28 Bionovo, Inc. Methods of detecting and treatment of cancers using scuttelaria barbata extract
US8197868B2 (en) 2007-11-19 2012-06-12 Bionovo, Inc. Process of making purified extract of Scutellaria barbata D. Don
JP2011522822A (ja) * 2008-06-06 2011-08-04 バイオノボ・インコーポレーテッド エストロゲン受容体β媒介性病状の治療のためのダイオウ（Ｒｈｅｕｍｐａｌｍａｔｕｍ）由来のアントラキノンおよび類似体
US9884815B2 (en) * 2011-10-14 2018-02-06 Emory University PGAM1 inhibitors and methods related thereto
CZ304335B6 (cs) * 2012-02-22 2014-03-12 Mikrobiologický ústav AV ČR, v. v. i. Submerzní kmeny Quambalaria sp. CCM 8372 a CCM 8373, směs naftochinonových barviv jimi produkovaná, způsob jejich produkce a použití
CA3105413A1 (en) * 2018-07-17 2020-01-23 Pili Anthraquinonic derivatives and their use as colouring agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA774443B (en) * 1977-07-22 1978-06-28 Allied Chem Anthrquinone compounds as anti-cancer agents
JPS6054286B2 (ja) * 1979-09-18 1985-11-29 江澤 林 免疫増強剤
JPS6043210A (ja) * 1983-08-18 1985-03-07 Tdk Corp 磁気ヘツド及びその製造方法
DE3431236A1 (de) * 1984-08-24 1986-02-27 Carnivora-Deutschland GmbH, 7109 Jagsthausen Verwendung von 1,4-naphthochinon-derivaten in niedrigen konzentrationen zur immunstimulation
DE3601065A1 (de) * 1986-01-16 1987-07-23 Behringwerke Ag Chinon-derivate als antitumormittel
ATE87204T1 (de) * 1987-12-10 1993-04-15 Tsumura & Co Anti-retrovirales arzneimittel.
ATE178311T1 (de) * 1988-08-16 1999-04-15 Wellcome Found Neue naphthochinone und ihre anwendung als arzneimittel
GB9103075D0 (en) 1991-02-13 1991-03-27 Washington Odur Ayuko Trinitrobenzene derivatives and their therapeutic use
AU662883B2 (en) * 1990-04-03 1995-09-21 Radopath Limited Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
DE4013023A1 (de) * 1990-04-24 1991-11-07 Lohmann Rudolf Lomapharm Verwendung von anthrachinonderivaten zur prophylaxe und therapie von viruserkrankungen

Also Published As

Publication number Publication date
IS3814A (is) 1992-08-14
BG61025B1 (bg) 1996-09-30
DZ1559A1 (fr) 2002-02-17
OA09535A (en) 1992-11-15
EP0499467A2 (en) 1992-08-19
GB2254554B (en) 1995-09-20
OA09810A (en) 1994-04-15
CN1064407A (zh) 1992-09-16
AP549A (en) 1996-11-01
IL100906A0 (en) 1992-11-15
NZ240487A (en) 1994-03-25
FI933595A7 (fi) 1993-08-13
SK87993A3 (en) 1993-12-08
GB9103075D0 (en) 1991-03-27
NO932681D0 (no) 1993-07-26
HUT65634A (en) 1994-07-28
BG98041A (bg) 1994-05-27
JPH06505231A (ja) 1994-06-16
MY131098A (en) 2007-07-31
MX9200622A (es) 1992-11-01
NZ241593A (en) 1995-05-26
BR9205642A (pt) 1994-06-21
FI933595A0 (fi) 1993-08-13
AU5590696A (en) 1996-08-08
IN178929B (OSRAM) 1997-07-19
NO932681L (no) 1993-10-07
LTIP329A (en) 1994-08-25
HU9302347D0 (en) 1993-10-28
CZ166893A3 (en) 1994-03-16
GB9203084D0 (en) 1992-03-25
LT3197B (en) 1995-03-27
AU1233992A (en) 1992-09-15
GT199200009A (es) 1993-08-06
AP9200356A0 (en) 1992-04-30
IL100906A (en) 1996-09-12
IE920464A1 (en) 1992-08-12
CA2104009A1 (en) 1992-08-14
JO1719B1 (en) 1992-12-15
WO1992014454A1 (en) 1992-09-03
ZA921037B (en) 1992-11-25
EP0499467A3 (en) 1992-12-16
MA22443A1 (fr) 1992-10-01
GB2254554A (en) 1992-10-14

Similar Documents

Publication Publication Date Title
TNSN92015A1 (fr) Composition pharmaceutique
Woolliams et al. Variation in the activities of glutathione peroxidase and superoxide dismutase and in the concentration of copper in the blood in various breed crosses of sheep
Yamashita et al. Inhibition of the Hill reaction by Tris and restoration by electron donation to photosystem II
McCord et al. Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein)
Keilin et al. Purification of horse-radish peroxidase and comparison of its properties with those of catalase and methaemoglobin
Voegtlin et al. On the mechanism of the action of arsenic upon protoplasm
Abu-Erreish et al. Age-related changes in cytochrome concentration of myocardial mitochondria
Boxer et al. Improvement of Chediak-Higashi leukocyte function by cyclic guanosine monophosphate
Adler et al. Distribution of glucose and lactate in the interphotoreceptor matrix
Holton et al. Water-soluble cytochromes from a blue-green alga. II. Physicochemical properties and quantitative relationships of cytochromes c (549, 552, and 554 Anacystis nidulans)
Sagone et al. The effect of sodium azide on the chemiluminescence of granulocytes—evidence for the generation of multiple oxygen radicals
US3721607A (en) Reagent composition and process for the determination of glucose
SU1393322A3 (ru) Средство дл определени @ - @ -Галактозидазы
Gibson et al. Metabolism and elimination of sulphite by rats, mice and monkeys
Metz et al. The effect of copper on the erythrocyte hexose monophosphate shunt pathway
Bratlid The effect of pH on bilirubin binding by human erythrocytes
Vassallo et al. NO2 gas and NO2-effects on alveolar macrophage phagocytosis and metabolism
Harvey et al. Oxidation of human and animal haemoglobins with ascorbate, acetylphenylhydrazine, nitrite, and hydrogen peroxide
Van Caneghem Influence of some hydrosoluble substances with vitamin P activity on the fragility of lysosomes in vitro
Matzanke et al. Hydroxamate siderophore mediated iron uptake in E. coli: stereospecific recognition of ferric rhodotorulic acid (1)
Rice Improved spectrophotometric determination of amylase with a new stable starch substrate solution
DE1213641C2 (de) Substrat zur bestimmung der konzentration des enzyms glutaminsaeure-oxylessigtransaminase in koerperfluessigkeiten
Ferguson et al. Potassium-specific uncoupling by nigericin
Sydenstrycker et al. Studies on a fast hemoglobin variant found in a Negro family in association with thalassemia
FR2446819A1 (fr) Derives 6-alkyles d&#39;acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant